Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 108 participants.

Also called NCT06471543

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 108 participants (planned count) (from the registry)
Sponsor
Ikaria Bioscience Pty Ltd (from the registry)
Registry
  • NCT NCT06471543
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06471543. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-30 (actual); primary completion 2026-06-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
Condition
Hypertriglyceridemia
Condition
Familial Chylomicronemia Syndrome
Intervention (Drug)
RN0361
Lead sponsor
Ikaria Bioscience Pty Ltd (class: industry)

Record details

Record id
cardio:ct-nct06471543
Content hash
1698993c3533aa9cb09d0b0383dae5e43b57ed982e7f8cd22174af8685f83535